Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
The stock carries a Zacks Rank #1 (Strong Buy) currently. Haemonetics' Plasma revenues grew 6% in the fourth quarter of fiscal 2024, driven primarily by disposable volume and software. The collections environment in the United States continued to be favorable, with disposables growing 4% in the quarter and 13% in fiscal 2024. The company is gaining from the newly-completed limited market release of the new Express Plus technology with more than 60,000 real-world collections. Haemonetics is currently initiating the full-market release of the new Express Plus technology in the United States. This technology is fast gaining new customers. The rollout of Persona — the company's proprietary technology proven to increase yield from 9% to 12% on average — continues to gain momentum, with more than 25 million collections. Advancements in NexLynk DMS (Donor Management System), its bidirectional connectivity software, are improving cycle times, reducing errors and allowing staff to focu
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (HAE) Expands VASCADE Line With New Limited Launch [Yahoo! Finance]Yahoo! Finance
- Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device [Yahoo! Finance]Yahoo! Finance
- Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure DevicePR Newswire
- Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $112.00 price target on the stock.MarketBeat
HAE
Earnings
- 5/9/24 - Beat
HAE
Sec Filings
- 6/7/24 - Form 4
- 6/7/24 - Form ARS
- 6/7/24 - Form DEFA14A
- HAE's page on the SEC website